Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Michael Garasic, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Januzzi JL, Garasic JM, Kasner SE, McDonald V, Petrie MC, Seltzer J, Mauro M, Croce K, Berman E, Deininger M, Hochhaus A, Pinilla-Ibarz J, Nicolini F, Kim DW, DeAngelo DJ, Kantarjian H, Xu J, Hall T, Srivastava S, Naranjo D, Cortes J. Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. J Hematol Oncol. 2022 Mar 23; 15(1):33. PMID: 35317837; PMCID: PMC8941744.
    Citations:    Fields:    
  2. Januzzi JL, Garasic JM, Kasner SE, McDonald V, Petrie MC, Seltzer J, Mauro M, Croce K, Berman E, Deininger M, Hochhaus A, Pinilla-Ibarz J, Nicolini F, Kim DW, DeAngelo DJ, Kantarjian H, Xu J, Hall T, Srivastava S, Naranjo D, Cortes J. Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. J Hematol Oncol. 2022 01 06; 15(1):1. PMID: 34991679; PMCID: PMC8734305.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  3. Drachman DE, Garasic JM. Paclitaxel-Coated Devices: Safety and Efficacy Are in the PVI of the Beholder. J Am Heart Assoc. 2021 02 16; 10(4):e020289. PMID: 33554617.
    Citations: 3     Fields:    
  4. McCarthy CP, Shrestha S, Ibrahim N, van Kimmenade RRJ, Gaggin HK, Mukai R, Magaret C, Barnes G, Rhyne R, Garasic JM, Januzzi JL. Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus. Open Heart. 2019; 6(1):e000955. PMID: 31217993.
    Citations: 1     Fields:    
  5. Ibrahim NE, McCarthy CP, Shrestha S, Lyass A, Li Y, Gaggin HK, Simon ML, Massaro JM, D'Agostino RB, Garasic JM, van Kimmenade RR, Januzzi JL. Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Am Heart J. 2019 03; 209:36-46. PMID: 30641399.
    Citations: 5     Fields:    Translation:Humans
  6. McCarthy CP, Ibrahim NE, van Kimmenade RRJ, Gaggin HK, Simon ML, Gandhi P, Kelly N, Motiwala SR, Mukai R, Magaret CA, Barnes G, Rhyne RF, Garasic JM, Januzzi JL. A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Cardiol. 2018 Jul; 41(7):903-909. PMID: 29876944.
    Citations: 5     Fields:    Translation:Humans
  7. Hynes BG, Kennedy KF, Ruggiero NJ, Kiernan TJ, Margey RJ, Rosenfield K, Garasic JM. Carotid artery stenting for recurrent carotid artery restenosis after previous ipsilateral carotid artery endarterectomy or stenting: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2014 Feb; 7(2):180-186. PMID: 24556097.
    Citations: 3     Fields:    Translation:Humans
  8. Giri J, Yeh RW, Kennedy KF, Hawkins BM, Weinberg I, Weinberg MD, Parikh SA, Garasic J, Jaff MR, White CJ, Rosenfield K. Unprotected carotid artery stenting in modern practice. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):595-602. PMID: 23804411.
    Citations: 4     Fields:    Translation:Humans
  9. Kiernan TJ, Yan BP, Eisenberg JD, Ruggiero NJ, Gupta V, Drachman D, Schainfeld RM, Jaff MR, Rosenfield K, Garasic J. Treatment of renal artery in-stent restenosis with sirolimus-eluting stents. Vasc Med. 2010 Feb; 15(1):3-7. PMID: 19793778.
    Citations: 4     Fields:    Translation:Humans
  10. Yan BP, Kiernan TJ, Rosenfield K, Garasic JM, de Moor M. Images in cardiovascular medicine. Dynamic left main coronary artery obstruction associated with Williams syndrome. Circulation. 2009 Jul 14; 120(2):181-2. PMID: 19597063.
    Citations:    Fields:    Translation:HumansCells
  11. Garasic JM, Marin L, Anderson RD. Acute evaluation of the Mynx vascular closure device during arterial re-puncture in an ovine model. J Invasive Cardiol. 2009 Jun; 21(6):283-5. PMID: 19494406.
    Citations: 2     Fields:    Translation:Animals
  12. Yan BP, Rosenfield K, Garasic JM, de Moor M. Carotid artery stent migration in a child with Williams syndrome. Pediatr Cardiol. 2009 May; 30(4):551-2. PMID: 19294459.
    Citations:    Fields:    Translation:Humans
  13. Korngold EC, Inglessis I, Garasic JM. A novel technique for 14 French arteriotomy closure after percutaneous aortic valvuloplasty using two Mynx closure devices. J Interv Cardiol. 2009 Apr; 22(2):179-83. PMID: 18973504.
    Citations:    Fields:    Translation:Humans
  14. Yan BP, Kiernan TJ, Gupta V, Schainfeld RM, Garasic JM. Images in cardiovascular medicine. Over rehearsed: a cellist with Paget-Schro√ętter. Circulation. 2008 Sep 16; 118(12):e160-1. PMID: 18794397.
    Citations: 1     Fields:    Translation:Humans
  15. Kiernan TJ, Yan BP, Gupta V, Garasic JM. Unusual case of recurrent renal artery stenosis: lessons to learn. Kidney Int. 2009 Jul; 76(2):224-8. PMID: 18633338.
    Citations:    Fields:    Translation:Humans
  16. Moukarbel GV, Jneid H, Walker JD, Garasic JM, Wang TJ. Aortic pseudoaneurysm compressing the left coronary artery. J Thorac Cardiovasc Surg. 2009 Jul; 138(1):236-7. PMID: 19577088.
    Citations:    Fields:    Translation:Humans
  17. Baron SJ, Yeh RW, Cruz-Gonzalez I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease. Catheter Cardiovasc Interv. 2008 Jul 01; 72(1):116-20. PMID: 18546237.
    Citations: 3     Fields:    Translation:Humans
  18. Januzzi JL, Garasic JM, Neilan TG, Gonzalez RG, Stone JR. Case records of the Massachusetts General Hospital. Case 28-2007. A 68-year-old man with syncope. N Engl J Med. 2007 Sep 13; 357(11):1137-45. PMID: 17855675.
    Citations: 2     Fields:    Translation:Humans
  19. Shetty SV, Kwolek CJ, Garasic JM. Percutaneous closure after inadvertent subclavian artery cannulation. Catheter Cardiovasc Interv. 2007 Jun 01; 69(7):1050-2. PMID: 17421015.
    Citations: 7     Fields:    Translation:Humans
  20. Kanani RS, Neilan TG, Palacios IF, Garasic JM. Novel use of the Amplatzer septal occluder device in the percutaneous closure of ascending aortic pseudoaneurysms: a case series. Catheter Cardiovasc Interv. 2007 Jan; 69(1):146-53. PMID: 17139656.
    Citations: 15     Fields:    Translation:Humans
  21. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation. 2006 May 16; 113(19):2278-84. PMID: 16682612.
    Citations: 124     Fields:    Translation:HumansCells
  22. Kanai R. Neilan T, Palacios I, Garasic J. Novel Use of the Amplatzer Septal Occluded Device in the Percutaneous Closure of Ascending Aortic Pseudoaneurysms: A Case Series. Catherization and Cardiovascular Interventions. 2006.
  23. Kanani RS, Garasic JM. Lower Extremity Arterial Occlusive Disease: Role of Percutaneous Revascularization. Curr Treat Options Cardiovasc Med. 2005 Jun; 7(2):99-107. PMID: 15935118.
  24. KananiR, Garasic,J.Lower Extremity Arterial Occulusive Disease: Role of Percutaneous Revascularization. 2005; 7, 99-107..
  25. Fernando D, Garasic J. Percutaneous intervention for renovascular disease: rationale and patient selection. Curr Opin Cardiol. 2004 Nov; 19(6):582-8. PMID: 15502502.
    Citations: 3     Fields:    Translation:Humans
  26. Garasic,J. Book Review. Topol's Textbook of Interventional Cardiology. 2003; 870.
  27. Garasic, J Eisnehauer A. . Endovascular Treatment of Cubclavian-Internal Mammary-Coronary Steal and the Vertebral Arteries. Fifty Cases of Peripheral Vascular Intervention. White,C, editor. 2002.
  28. Garasic JM, Creager MA. Percutaneous interventions for lower-extremity peripheral atherosclerotic disease. Rev Cardiovasc Med. 2001; 2(3):120-5. PMID: 12439376.
    Citations: 1     Fields:    Translation:Humans
  29. Garasic J. Eisnehauer AC. Percutaneous Interventions for Obstructive Atherosclerotic Peripheral Arterial Disease. THrombosis and Thrombolembolism. Goldhaber S. Ridker P. editors. 2001.
  30. Garasic J. Creager M. Percutaneous Interventiona for Lower Extremity Peripheral Atherosclerotic Disease. Faxon D, editor. 2001.
  31. Garasic,J, Eisenhauer, AC. Pulmonary Angiography. 2001.
  32. Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 2000 Feb 22; 101(7):812-8. PMID: 10683357.
    Citations: 29     Fields:    Translation:Animals
  33. Garasic J. Rogers, C. Edelman, ER. . Stent Design and the Biologic Response. Frontiers in Interventional Cardiology. Beyer R, Leon M, Serruys P and Shapiro D. editors. 1997.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Garasic's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (169)
Co-Authors (26)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.